GLP-1 Market
LLY $1181.89 ▲ +2.7% NVO $38.62 ▲ +1.2% PFE $28.41 ▲ +0.8% VKTX $36.75 ▼ -11.8% KLRA $11.98 ▼ -8.8% GPCR $36.02 ▲ +0.2% RHHBY $54.80 ▼ -0.5%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Active comparator Taurine

Company
Hospital de Clinicas de Porto Alegre
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
13 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

13 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 25, 2026

Find a Clinical Trial Near Me

See recruiting studies for Active comparator Taurine and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04874012

    Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes

    Not yet reported Hospital de Clinicas de Porto Alegre 94 participants Est. completion 2026-12-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06128252

    Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer

    Not yet reported Tang-Du Hospital 96 participants Est. completion 2027-06-30 15 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06269627

    Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

    Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 48 participants Est. completion 2026-12-31 1 site
    Alcohol use disorder
    View official trial listing →
  • Recruiting NCT NCT06721949

    Taurine Supplementation in Long COVID

    Not yet reported, Not yet reported University of Alberta 300 participants Est. completion 2028-12 5 sites Stand-alone
    Other conditions: Long COVID
    View official trial listing →
  • Recruiting NCT NCT06847555

    Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury

    Not yet reported, Not yet reported Shandong Cancer Hospital and Institute 24 participants Est. completion 2027-09-25 1 site Stand-alone
    Other conditions: To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients
    View official trial listing →
  • Recruiting NCT NCT07029178

    Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis

    Not yet reported Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 160 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Radiation Induced Oral Mucositis, Radiodermatitis
    View official trial listing →
  • Recruiting NCT NCT07060638

    Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

    Not yet reported Samer Gawrieh 216 participants Est. completion 2029-12 6 sites
    Other conditions: Alcohol-associated Hepatitis
    View official trial listing →
  • Recruiting NCT NCT07115563

    Daily Amino Acid Supplementation for People With Parkinson's Disease

    Not yet reported Cristina Colon-Semenza 30 participants Est. completion 2027-11 2 sites Stand-alone
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07212803

    Effects of Energy Drinks on Cardiovascular Endpoints

    Not yet reported University of the Pacific 3 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Healthy Volunteers, Safety After Oral Intake
    View official trial listing →
  • Recruiting NCT NCT07312409

    Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?

    York University 30 participants Est. completion 2027-12-31 1 site
    Other conditions: Long COVID Syndrome
    View official trial listing →
  • Recruiting NCT NCT07487623

    Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).

    Not yet reported University of Guadalajara 26 participants Est. completion 2026-05-15 2 sites Stand-alone
    Other conditions: Liver Disease Chronic, HEPATITIS C VIRUS CHRONIC INFECTION
    View official trial listing →
  • Recruiting NCT NCT07654946

    Near-Infrared Spectroscopy, Acute Taurine Supplementation, and Isolated Muscular Endurance and Fatigue Resistance in Young Healthy Adults

    Not yet reported Louisiana State University and A&M College 34 participants Est. completion 2027-01-15 1 site Stand-alone
    Other conditions: Local Muscular Endurance and Fatigue, NIRS Skeletal Muscle Mitochondrial Capacity, Acute Taurine Supplementation
    View official trial listing →
  • Recruiting NCT NCT07710547

    TCP-600 Supplementation and Performance Response in Professional Football Players

    Not yet reported Vizja University in Warsaw 65 participants Est. completion 2026-10 3 sites Stand-alone
    Other conditions: Athletic Performance, Cognitive Fatigue, Exercise Recovery, Football-Specific Performance, Perceptual-cognitive Performance
    View official trial listing →
  • Completed NCT NCT00004552

    Acamprosate Treatment: Mechanisms of Action

    Not yet reported Yale University 120 participants Est. completion 2002-12 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00006206

    COMBINE (Acamprosate/Naltrexone)

    Not yet reported University of North Carolina, Chapel Hill 1375 participants Est. completion 2006-05 12 sites
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00106106

    Acamprosate to Reduce Symptoms of Alcohol Withdrawal

    Not yet reported National Institutes of Health Clinical Center (CC) 56 participants Est. completion 2010-07 1 site
    Alcohol use disorder Other conditions: Alcohol-Related Disorders, Alcoholism, Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT00120601

    Trial for the Treatment of Alcohol Dependence

    Not yet reported University of Sydney 200 participants Est. completion 2005-06 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Status unknown NCT NCT00135044

    A Trial of Taurine Supplementation in Parenteral Nutrition 1

    Not yet reported London North West Healthcare NHS Trust 24 participants 1 site
    Other conditions: Cholestasis
    View official trial listing →
  • Completed NCT NCT00159107

    Integrative Therapy in Alcoholism

    Not yet reported Heinrich-Heine University, Duesseldorf 371 participants Est. completion 2006-12 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00217165

    Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

    Not yet reported Mclean Hospital 60 participants Est. completion 2011-12 1 site
    Other conditions: Bipolar Disorder, Mania, Bipolar Depression
    View official trial listing →
  • Terminated NCT NCT00249379

    Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees

    Not yet reported Virginia Commonwealth University 26 participants Est. completion 2008-08 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT00317031

    Individually Adapted Therapy of Alcoholism

    Not yet reported Central Institute of Mental Health, Mannheim 435 participants Est. completion 2008-06 5 sites
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00330174

    Acamprosate in Alcoholics With Comorbid Anxiety or Depression

    Not yet reported Medical University of South Carolina 90 participants Est. completion 2010-09 3 sites
    Alcohol use disorder Other conditions: Major Depression, Social Anxiety Disorder, Generalized Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT00330486

    Open Label Trial of Acamprosate in Bipolar Alcoholics

    Not yet reported, Not yet reported Medical University of South Carolina 9 participants Est. completion 2007-06 1 site
    Alcohol use disorder Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00360594

    Acamprosate Initiated During Alcohol Detoxification

    Not yet reported Forest Laboratories 40 participants Est. completion 2007-11 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT00381043

    Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic

    Not yet reported University of North Carolina, Chapel Hill 100 participants Est. completion 2008-07 2 sites
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT00385268

    Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence

    Not yet reported University of Pennsylvania 60 participants Est. completion 2008-07 1 site
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Terminated NCT NCT00391001

    Taurine in Adolescents With Bipolar Disorder

    Not yet reported Cambridge Health Alliance 4 participants Est. completion 2007-08 2 sites Stand-alone
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00420823

    A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment

    Not yet reported, Not yet reported Melbourne Health 121 participants Est. completion 2010-12 2 sites Stand-alone
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Terminated NCT NCT00425711

    Study of Acamprosate in Driving Under the Influence (DUI) Court Participants

    Not yet reported University of Oklahoma 4 participants Est. completion 2009-12 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT00435435

    Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence

    Not yet reported Finnish Institute for Health and Welfare 243 participants Est. completion 2005-04 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT00452543

    Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism

    Not yet reported Massachusetts General Hospital 23 participants Est. completion 2010-05 1 site
    Alcohol use disorder Other conditions: Major Depressive Disorder, Alcohol Abuse
    View official trial listing →
  • Completed NCT NCT00463346

    Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

    Not yet reported Yale University 23 participants Est. completion 2015-07 1 site
    Alcohol use disorder Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00466661

    Acamprosate vs. Placebo in Bipolar Alcoholics

    Not yet reported Medical University of South Carolina 33 participants Est. completion 2010-02 1 site
    Alcohol use disorder Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00497978

    The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient

    Not yet reported Medical Center Alkmaar 236 participants Est. completion 2011-10 1 site
    Other conditions: Insulin Resistance, Elderly Patient, Oxidative Stress
    View official trial listing →
  • Completed NCT NCT00511940

    Acamprosate in the Treatment of Binge-Eating Disorder

    Not yet reported, Not yet reported Lindner Center of HOPE 40 participants Est. completion 2011-01 1 site
    Other conditions: Binge Eating Disorder
    View official trial listing →
  • Completed NCT NCT00571103

    Acamprosate in the Treatment of Pathological Gambling

    Not yet reported University of Iowa 26 participants Est. completion 2009-07
    Other conditions: Pathological Gambling
    View official trial listing →
  • Completed NCT NCT00571922

    A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction

    Not yet reported, Not yet reported NYU Langone Health 72 participants Est. completion 2008-11 1 site
    Other conditions: Methamphetamine Dependence, Treatment Seeking
    View official trial listing →
  • Completed NCT NCT00591565

    An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants

    Not yet reported State University of New York - Upstate Medical University 13 participants Est. completion 2009-12 1 site
    Other conditions: Anxiety
    View official trial listing →
  • Completed NCT NCT00596531

    Clinical Trial of Acamprosate for Tinnitus

    Not yet reported Oregon Health and Science University 154 participants Est. completion 2013-11 1 site
    Other conditions: Tinnitus
    View official trial listing →
  • Completed NCT NCT00605904

    Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics

    Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 37 participants Est. completion 2011-03 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Withdrawn NCT NCT00640952

    Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease

    Not yet reported Baylor College of Medicine Est. completion 2008-09 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Withdrawn NCT NCT00655967

    Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE)

    Not yet reported University of New Mexico Est. completion 2006-12 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT00656630

    Medication Development in Alcoholism: Acamprosate Versus Naltrexone

    Not yet reported The Scripps Research Institute 68 participants Est. completion 2010-01 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00662571

    Acamprosate: Genes Associated With Response

    Mayo Clinic 485 participants Est. completion 2013-02 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00688324

    Biomarker Study of Acamprosate in Schizophrenia

    Not yet reported University of Maryland, Baltimore 36 participants Est. completion 2012-02 4 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00855699

    Alcohol Detoxification in Primary Care Treatment (ADEPT)

    Not yet reported University of Bristol 36 participants Est. completion 2010-11 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Terminated NCT NCT01062724

    Total Parenteral Nutrition Associated Cholestasis (TPNAC) and Plasma Amino Acid Levels in Neonates

    Not yet reported Coordinación de Investigación en Salud, Mexico 94 participants Est. completion 2016-07 1 site
    Other conditions: Premature Birth
    View official trial listing →
  • Completed NCT NCT01073332

    The Effects of a Dietary Supplement on Exercise Performance in Healthy Older Adults"

    Not yet reported University of California, Los Angeles 16 participants Est. completion 2005-02 1 site Stand-alone
    Other conditions: Excessive Physical Exercise, Unspecified
    View official trial listing →
  • Completed NCT NCT01192828

    Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine

    Not yet reported, Not yet reported University of Colorado, Denver 15 participants Est. completion 2017-12 4 sites Stand-alone
    Other conditions: Homocystinuria
    View official trial listing →
  • Status unknown NCT NCT01226537

    Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients

    Not yet reported, Not yet reported Hamad Medical Corporation 20 participants Est. completion 2014-12
    Other conditions: it is a Group of Metabolic Diseases in, Which a Person Has High Blood Sugar, Either, Because the Body Does Not Produce Enough Insulin,, or Because Cells do Not Respond to the Insulin That, is Produced.
    View official trial listing →
  • Completed NCT NCT01300923

    Acamprosate in Youth With Fragile X Syndrome

    Not yet reported Indiana University 14 participants Est. completion 2011-09 1 site
    Other conditions: Fragile X Syndrome, Autism Spectrum Disorders
    View official trial listing →
  • Completed NCT NCT01302509

    Enteral Nutrition in Cancer Patient

    Not yet reported Grupo de Apoio ao Adolescente e a Crianca com Cancer
    Other conditions: Malnutrition, Cancer, Pediatric
    View official trial listing →
  • Completed NCT NCT01304446

    Enteral Nutrition in Cancer Patients

    Not yet reported Grupo de Apoio ao Adolescente e a Crianca com Cancer Stand-alone
    Other conditions: Malnutrition, Cancer
    View official trial listing →
  • Completed NCT NCT01381354

    Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

    Not yet reported University of Iowa 38 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01421979

    Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans

    Not yet reported University of Hohenheim 38 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Cardiovascular Risk
    View official trial listing →
  • Completed NCT NCT01426750

    Enteral Nutrition Support in Children and Adolescents With Cancer

    Not yet reported Grupo de Apoio ao Adolescente e a Crianca com Cancer Est. completion 2006-06 Stand-alone
    Other conditions: Malnutrition, Cancer
    View official trial listing →
  • Completed NCT NCT01599169

    Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome

    Not yet reported Université Victor Segalen Bordeaux 2 87 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Efficacy and Tolerance of B-Back® on the Burnout Syndrome
    View official trial listing →
  • Completed NCT NCT01608178

    Taurine Therapy for SSADH Deficiency

    National Institute of Neurological Disorders and Stroke (NINDS) 7 participants Est. completion 2013-12-16 1 site
    Other conditions: Succinic Semialdehyde Dehydrogenase
    View official trial listing →
  • Completed NCT NCT01813318

    Study of Acamprosate in Autism

    Not yet reported Children's Hospital Medical Center, Cincinnati 36 participants Est. completion 2017-09-07 1 site
    Other conditions: Autistic Disorder
    View official trial listing →
  • Completed NCT NCT01816698

    Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive

    Not yet reported Zhiming Zhu 120 participants Est. completion 2015-03 1 site
    Other conditions: Prehypertension
    View official trial listing →
  • Completed NCT NCT01911455

    Study of Acamprosate in Fragile x Syndrome

    Not yet reported Children's Hospital Medical Center, Cincinnati 46 participants Est. completion 2018-11-08 2 sites
    Other conditions: Fragile X Syndrome
    View official trial listing →
  • Withdrawn NCT NCT02064010

    A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

    Not yet reported Synchroneuron Inc. Est. completion 2015-12 1 site
    Other conditions: Drug-induced Tardive Dyskinesia
    View official trial listing →
  • Withdrawn NCT NCT02217007

    A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome

    Not yet reported Synchroneuron Inc. Est. completion 2016-02 2 sites
    Other conditions: Tourette Syndrome
    View official trial listing →
  • Completed NCT NCT02313883

    A Phase I/II Study to Evaluate the Safety and Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis

    Not yet reported, Not yet reported Geistlich Pharma AG 127 participants Est. completion 2018-07-02 4 sites Stand-alone
    Other conditions: Periodontitis
    View official trial listing →
  • Completed NCT NCT02344719

    Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis

    Not yet reported Medical University of Vienna 30 participants Est. completion 2015-06 1 site
    Other conditions: Cirrhosis, Portal Hypertension
    View official trial listing →
  • Terminated NCT NCT02374567

    Pharmacovigilance in Gerontopsychiatric Patients

    Not yet reported Hannover Medical School 407 participants Est. completion 2017-06-28 5 sites
    Other conditions: Dementia, Depression, Schizophrenia, Psychosomatic Disorders, Anxiety Disorders
    View official trial listing →
  • Completed NCT NCT02418130

    A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Ursa Complex Soft Cap. (UDCA-004)' in Patients With Physical Fatigue.

    Not yet reported Daewoong Pharmaceutical Co. LTD. 166 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Fatigue
    View official trial listing →
  • Completed NCT NCT02535143

    Impact of Energy Drinks on the Manual Dexterity of Final Year Dental Students

    Not yet reported Riyadh Colleges of Dentistry and Pharmacy 60 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Hand Skill, Relative
    View official trial listing →
  • Completed NCT NCT02649777

    Normal Values of Oxidative Stress, Taurine, and Related Markers

    University of Colorado, Denver 22 participants Est. completion 2017-12 1 site
    Other conditions: Oxidative Stress
    View official trial listing →
  • Completed NCT NCT02727920

    Effects of Energy Drinks

    Not yet reported Johns Hopkins Bloomberg School of Public Health 228 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Energy Drinks
    View official trial listing →
  • Completed NCT NCT02771587

    Interaction of Alcohol With Energy Drinks

    Not yet reported Parc de Salut Mar 16 participants Est. completion 2016-09 2 sites
    Other conditions: Alcohol-Related Disorders, Drinking and Driving
    View official trial listing →
  • Completed NCT NCT02780219

    Chronic Obstructive Pulmonary Disorder and Acute Exercise

    Not yet reported Texas A&M University 57 participants Est. completion 2020-03-06 1 site Stand-alone
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Terminated NCT NCT02930161

    Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

    Not yet reported POLYSAN Scientific & Technological Pharmaceutical Company 35 participants Est. completion 2018-10-10 3 sites Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT02998151

    Neurophysiological and Acute Pharmacological Studies in FXS Patients

    Not yet reported Children's Hospital Medical Center, Cincinnati 29 participants Est. completion 2020-11 1 site
    Other conditions: Fragile X Syndrome
    View official trial listing →
  • Completed NCT NCT03155919

    Taurine Supplementation and Triathletes

    Not yet reported University of Sao Paulo 15 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Athletic Proteinuria
    View official trial listing →
  • Status unknown NCT NCT03410173

    Taurine Supplementation on Cognitive Function in Patients With Diabetes

    Not yet reported Third Military Medical University 200 participants Est. completion 2018-06 1 site Stand-alone
    Other conditions: Taurine, Cognitive Decline, Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT03410537

    Taurine Supplementation on Lower Extremity Vasculopathy in Patients With Diabetes

    Not yet reported Third Military Medical University 200 participants Est. completion 2018-06 1 site Stand-alone
    Other conditions: Taurine, Diabetes, Lower Extremity Artery Disease
    View official trial listing →
  • Withdrawn NCT NCT03420976

    Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth

    Not yet reported Atrium Innovations Est. completion 2019-02-01 1 site Stand-alone
    Other conditions: Small Intestinal Bacterial Overgrowth
    View official trial listing →
  • Terminated NCT NCT03462940

    Effects of TUDCA on Endothelial Function in Type 2 DM

    Not yet reported Boston University 2 participants Est. completion 2021-02-09 1 site Stand-alone
    Type 2 diabetes Other conditions: Insulin Response, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT03480295

    Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

    Not yet reported Fondazione G.B. Bietti, IRCCS 39 participants Est. completion 2017-04-27 Stand-alone
    Other conditions: Glaucoma
    View official trial listing →
  • Completed NCT NCT03550885

    Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk

    Not yet reported University of Illinois at Chicago 15 participants Est. completion 2021-12-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03634917

    Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence

    Not yet reported Technische Universität Dresden 82 participants Est. completion 2024-05-01 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT03655041

    24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

    Not yet reported University of Sao Paulo 25 participants Est. completion 2017-12-15
    Other conditions: Sports Nutritional Physiological Phenomena
    View official trial listing →
  • Completed NCT NCT03818191

    Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome

    Not yet reported Mayo Clinic 288 participants Est. completion 2023-11-04 3 sites
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT03907267

    Taurine in Peripartum Cardiomyopathy

    Not yet reported, Not yet reported Ain Shams University 40 participants Est. completion 2020-01-01 1 site Stand-alone
    Other conditions: Peripartum Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT03936712

    Effect of Energy Drink on Sport Performance and Psycho-Physiological Responses.

    Not yet reported The Higher Institute of Sport and Physical Education of Sfax 22 participants Est. completion 2017-01-12 Stand-alone
    Other conditions: Physical Activity
    View official trial listing →
  • Suspended NCT NCT04015557

    Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria

    Not yet reported, Not yet reported Hospital de Clinicas de Porto Alegre 10 participants Est. completion 2022-12-01 1 site
    Other conditions: CBS Deficiency
    View official trial listing →
  • Completed NCT NCT04047043

    Evaluation of Serum Taurine as a Prognostic Marker for Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant

    Ain Shams University 60 participants Est. completion 2020-05-30 1 site
    Other conditions: Taurine
    View official trial listing →
  • Completed NCT NCT04147741

    Effects of a Pre-Workout on Performance, Perceptual Responses, Energy Feelings and Muscular Properties, After a Training Microcycle in Adults.

    Not yet reported University of Greenwich 16 participants Est. completion 2020-03-21 1 site Stand-alone
    Other conditions: Protein Deficiency, Training Group, Sensitivity, Fatigue, Muscular Atrophy, Psychological
    View official trial listing →
  • Status unknown NCT NCT04149717

    The Effect of Energy Drink Ingredients on Cardiovascular Function in Men and Women 18-39 Years Old

    Not yet reported Duquesne University 35 participants Est. completion 2023-03 1 site Stand-alone
    Other conditions: Cardiac Arrhythmia, Blood Pressure
    View official trial listing →
  • Completed NCT NCT04192539

    The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers

    Not yet reported Ain Shams University 116 participants Est. completion 2018-12-17 1 site
    Other conditions: Taurine in Cancer Colon
    View official trial listing →
  • Completed NCT NCT04193761

    TAURINE and HCC PATIENTS

    Not yet reported Ain Shams University 100 participants Est. completion 2018-10-25 1 site
    Other conditions: Taurine in HCC
    View official trial listing →
  • Completed NCT NCT04279600

    Taurine Supplementation and Training Effects on Energy Metabolism, Inflammation and Oxidative Stress in Obese Women

    Not yet reported University of Sao Paulo 24 participants Est. completion 2018-05-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT04287790

    Promoting Medications for Alcohol Use Disorder on the General Medicine Service

    Yale University 67 participants Est. completion 2021-02-01 1 site
    Alcohol use disorder
    View official trial listing →
  • Status unknown NCT NCT04291352

    Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation

    Not yet reported University Health Network, Toronto 60 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Thalassemia Major
    View official trial listing →
  • Status unknown NCT NCT04498897

    Vortioxetine for Treatment of Depressive Mood and Alcohol Use

    Not yet reported Hanyang University Seoul Hospital 128 participants Est. completion 2021-04-04 1 site
    Other conditions: Depressive Disorder, Major, Alcoholism
    View official trial listing →
  • Status unknown NCT NCT04516421

    Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia

    Not yet reported Asia University 80 participants Est. completion 2022-06-30 3 sites Stand-alone
    Other conditions: Sarcopenia
    View official trial listing →
  • Status unknown NCT NCT04630977

    Long-term Intervention Effects of a Personalized, Home-based Exercise Program and Nutritional Advice, Along With the Inclusion of a Pre-workout Multi-ingredient Supplement on the Body Composition, Functional Capacity and Quality of Life of Middle-aged and Older Adults (40-70 Years)

    Not yet reported University of Greenwich 3000 participants Est. completion 2023-05-28 1 site Stand-alone
    Other conditions: Muscle Loss, Obesity, Obesity, Abdominal, Weight Loss, Happiness, Quality of Life, Self-Perception, Stress, Psychological
    View official trial listing →
  • Completed NCT NCT04646512

    Taurine Supplementation and Exercise on Irisin Levels in Obesity

    Not yet reported University of Sao Paulo 31 participants Est. completion 2016-08-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04772508

    Effect of Amnion Membrane With and Without Taurine on GCF TNF α Level.

    Not yet reported Maharishi Markendeswar University (Deemed to be University) 45 participants Est. completion 2021-03-13 1 site
    Other conditions: Periodontitis
    View official trial listing →
  • Terminated NCT NCT04784234

    Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

    Not yet reported Wills Eye 12 participants Est. completion 2022-10-27 1 site
    Other conditions: Primary Open Angle Glaucoma
    View official trial listing →
  • Completed NCT NCT04790188

    Effect of a Nootropic on the Cognitive Performance in Young Adults

    Not yet reported Universidad de Granada 25 participants Est. completion 2022-05-15 1 site Stand-alone
    Other conditions: Cognitive Change
    View official trial listing →
  • Completed NCT NCT04961086

    Health Effect of Energy Drink Consumption

    Not yet reported Dow University of Health Sciences 76 participants Est. completion 2022-09-01 1 site Stand-alone
    Other conditions: Blood Pressure, Blood Glucose, High, Cognitive Change
    View official trial listing →
  • Suspended NCT NCT04984577

    Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke

    Not yet reported Nanjing Yoko Biomedical Co., Ltd. 240 participants Est. completion 2026-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05149716

    Taurine as a Possible Anti-aging Therapy?

    Not yet reported University of Sao Paulo 24 participants Est. completion 2020-07-03 1 site Stand-alone
    Other conditions: Oxidative Stress
    View official trial listing →
  • Completed NCT NCT05333315

    Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults

    Not yet reported University of Primorska 120 participants Est. completion 2022-07-15 1 site Stand-alone
    Other conditions: Overweight and Obesity, Inflammation, Hypercholesterolemia, Hypertension
    View official trial listing →
  • Completed NCT NCT05342272

    Comparison of Gum® HydralTM Moisturizing Gel and Biotene® Oral Gel in Dry Mouth Sensation Reduction

    Not yet reported Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 40 participants Est. completion 2018-10-30 2 sites Stand-alone
    Other conditions: Xerostomia
    View official trial listing →
  • Status unknown NCT NCT05415176

    Taurine Supplementation Associated or Not With Exercise: Effect on Browning of White Adipose Tissue in Elderly Women With Sarcopenic Obesity

    Not yet reported University of Sao Paulo 40 participants Est. completion 2024-06-01 1 site Stand-alone
    Other conditions: Browning of Subcutaneous White Adipose Tissue Post Intervention, Metabolic and Inflammatory Variables Post Intervention
    View official trial listing →
  • Status unknown NCT NCT05437952

    Metabolic and Molecular Responses Under the Effect of Taurine Supplementation With and Without Multicomponent Training

    Not yet reported University of Sao Paulo 60 participants Est. completion 2022-12 Stand-alone
    Other conditions: Sarcopenic Obesity
    View official trial listing →
  • Completed NCT NCT05551637

    Evaluating Oral Nutritional Supplements on Children's Nutritional Status and Digestive Health in Vietnam.

    Not yet reported Tu Nguyen Song 600 participants Est. completion 2023-08-01 1 site Stand-alone
    Other conditions: Undernutrition, Wasting, Malnourished
    View official trial listing →
  • Completed NCT NCT05570045

    Improvement of Nutrition Status, Digestive Conditions, and Upper Respiratory Infections by Using Oral Nutritional Supplementation on Children in Vietnam

    Not yet reported Tu Nguyen Song 600 participants Est. completion 2023-08-01 1 site Stand-alone
    Other conditions: Wasting, Undernutrition, Malnourished, Malnutrition
    View official trial listing →
  • Completed NCT NCT05586295

    Vitamin B Complex Improved Exercise Performance and Anti-fatigue

    Not yet reported National Taiwan Sport University 32 participants Est. completion 2021-06-26 1 site Stand-alone
    Other conditions: Exercise Performance, Fatigue
    View official trial listing →
  • Completed NCT NCT05733364

    Effect of 4 Weeks Supplementation of a Combination of Vitamin Bs and Taurine on Mental Performance in Healthy Adults

    Not yet reported Société des Produits Nestlé (SPN) 45 participants Est. completion 2023-12-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05769088

    Effects of a Multi-Ingredient Pre-Workout Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing in Adults.

    Not yet reported Joel Puente 40 participants Est. completion 2023-05-30 1 site Stand-alone
    Other conditions: Protein Deficiency, Training Group, Sensitivity, Fatigue, Muscular Atrophy, Psychological
    View official trial listing →
  • Completed NCT NCT05953064

    Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects

    Not yet reported University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2023-10-31 1 site
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT05980520

    Study on the Treatment of Taurine in Children With Autism

    Not yet reported Guizhou Provincial People's Hospital 64 participants Est. completion 2025-02-28 1 site Stand-alone
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT06019858

    A Clinical Trial to Assess the Effects of a Vitamin Shot on Energy Levels

    Not yet reported Vitamin Energy® 30 participants Est. completion 2023-07-20 1 site Stand-alone
    Other conditions: Energy, Fatigue, Mood, Weight Loss, Cognition
    View official trial listing →
  • Status unknown NCT NCT06123455

    Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer

    Not yet reported Tang-Du Hospital 60 participants Est. completion 2025-07-31 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT06137248

    Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption

    Not yet reported University of Florida 76 participants Est. completion 2025-04-17 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT06137833

    Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy

    Not yet reported Pharmanutra S.p.a. 92 participants Est. completion 2025-12-31 5 sites Stand-alone
    Other conditions: Fatigue, Breast Cancer
    View official trial listing →
  • Completed NCT NCT06146387

    Improved Cognitive Outcomes Associated With Feihe HMO With DHA/ARA in Infant Formula

    Not yet reported Heilongjiang Feihe Dairy Co. Ltd. 240 participants Est. completion 2025-04-03 3 sites Stand-alone
    Other conditions: Cognitive Change
    View official trial listing →
  • Completed NCT NCT06158659

    Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula

    Not yet reported Heilongjiang Feihe Dairy Co. Ltd. 240 participants Est. completion 2025-04-03 3 sites Stand-alone
    Other conditions: Flu, Cold
    View official trial listing →
  • Completed NCT NCT06159088

    Improved Gut Health Outcomes Associated With Probiotics Fortified With Hydrolyzed Whey Protein in Infant Formula

    Not yet reported Heilongjiang Feihe Dairy Co. Ltd. 240 participants Est. completion 2025-04-03 3 sites Stand-alone
    Other conditions: Gut Health, Gastrointestinal Diseases
    View official trial listing →
  • Withdrawn NCT NCT06312800

    Acamprosate and Methazolamide for Essential Tremor

    Not yet reported Henry Ford Health System Est. completion 2017-12 1 site
    Other conditions: Essential Tremor
    View official trial listing →
  • Completed NCT NCT06363669

    Effects of Caffeine-based Supplement on Physical Performance

    Not yet reported University School of Physical Education, Krakow, Poland 12 participants Est. completion 2024-03-30 1 site Stand-alone
    Other conditions: Muscle Power
    View official trial listing →
  • Completed NCT NCT06384586

    Investigation of Dietary Supplement Liquid Shot Products on Mental Energy, Cognition (Acuity),and Mood

    Not yet reported The Water Street Collective 45 participants Est. completion 2022-12-22 1 site Stand-alone
    Other conditions: Cognition, Mental Fatigue, Mood
    View official trial listing →
  • Completed NCT NCT06471686

    Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations

    Not yet reported University of Southern California 30 participants Est. completion 2023-10-30 1 site
    Alcohol use disorder Other conditions: Liver Transplant; Complications
    View official trial listing →
  • Active, not recruiting NCT NCT06579508

    Effects of High-intensity Exercise With Hypoxia and Taurine Supplementation on Metabolic and Mitochondrial Parameters

    Not yet reported University of Sao Paulo 50 participants Est. completion 2026-12 2 sites
    Other conditions: Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT06607068

    Assessment of Taurine Concentration in Older Women With/Without Obesity And With/Without Type 2 Diabetes Mellitus

    University of Sao Paulo 40 participants Est. completion 2026-01-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06613542

    Effects Of Daily Taurine Intake For 6 Months On Biological Age and Body Metabolism Indicators As Well As Physical Fitness In 55-75-year-old Women And Men

    Not yet reported Technical University of Munich 90 participants Est. completion 2025-11-13 1 site
    Other conditions: Taurine, Aging, Biological, Physical Activity, Metabolic Health, Anti-Aging, Longevity, Dietary Supplement, DNA Methylation, Sport
    View official trial listing →
  • Completed NCT NCT06635369

    Taurine in Periodontitis and Aging

    Not yet reported Istanbul Medipol University Hospital 66 participants Est. completion 2024-06-01 1 site
    Other conditions: Peridontal Disease, Aging
    View official trial listing →
  • Active, not recruiting NCT NCT06639711

    Taurine Eye Drops May Prevent the Progression of Cataract

    Not yet reported, Not yet reported University Of Anbar 50 participants Est. completion 2024-12-20 1 site Stand-alone
    Other conditions: Cataract
    View official trial listing →
  • Completed NCT NCT06801951

    Oral Supplement and Acute Resistance Exercise

    Not yet reported Texas A&M University 16 participants Est. completion 2020-02-27 1 site Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT06824571

    Effects of Taurine Supplementation on Repetitive Sprint Performance and Exhaustion Time in College Students Under High-Temperature and High-Humidity Conditions

    Not yet reported Xiaodong Cheng 16 participants Est. completion 2025-01-09 1 site Stand-alone
    Other conditions: Exercise Performance in Extreme Environments
    View official trial listing →
  • Completed NCT NCT06884566

    Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power

    Not yet reported University of Central Lancashire Cyprus 17 participants Est. completion 2025-01-21 1 site Stand-alone
    Other conditions: Taurine
    View official trial listing →
  • Completed NCT NCT06899620

    BC179 Relieves Discomfort After Drinking

    Not yet reported Wecare Probiotics Co., Ltd. 60 participants Est. completion 2025-07-20 1 site
    Other conditions: Drinking Behavior
    View official trial listing →
  • Not yet recruiting NCT NCT07144033

    Butyrate and Taurine for Chronic Postsurgical Pain in Adult Cardiac Surgical Patients

    Not yet reported Chinese University of Hong Kong 216 participants Est. completion 2028-01-31 1 site Stand-alone
    Other conditions: Pain, Acute, Pain, Chronic, Chronic Post Operative Pain
    View official trial listing →
  • Active, not recruiting NCT NCT07204977

    Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 30 participants Est. completion 2028-09-30 1 site
    Other conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07263607

    A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis

    Not yet reported Sichuan Academy of Medical Sciences 80 participants Est. completion 2029-11 Stand-alone
    Other conditions: Multiple Sclerosis (MS) Relapsing Remitting
    View official trial listing →
  • Completed NCT NCT07400614

    Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period

    Not yet reported PepsiCo Global R&D 48 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: Alertness
    View official trial listing →
  • Not yet recruiting NCT NCT07457632

    Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.

    Not yet reported University of Alabama at Birmingham 69 participants Est. completion 2028-12-31 1 site
    Other conditions: Diabetic Macular Edema (DME)
    View official trial listing →
  • Completed NCT NCT07466654

    Low-Dose Caffeine and Taurine Effects on Performance

    Not yet reported Ankara University 32 participants Est. completion 2025-11-15 1 site Stand-alone
    Other conditions: Anaerobic Performance Neuromuscular Performance Cognitive Performance
    View official trial listing →
  • Active, not recruiting NCT NCT07556016

    Evaluation of the Performance of a Nutricosmetic on Hair & Scalp in Women and Men After 3 and 6 Months

    Not yet reported L'Oreal 239 participants Est. completion 2026-07-31 4 sites Stand-alone
    Other conditions: Hair Loss
    View official trial listing →
  • Not yet recruiting NCT NCT07567742

    Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma

    Not yet reported Sun Yat-sen University 130 participants Est. completion 2029-03-30 1 site Stand-alone
    Other conditions: Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC)
    View official trial listing →
  • Completed NCT NCT07580248

    Effects of Supplementation on Performance in Football Players

    Not yet reported Krzysztof Mizera 81 participants Est. completion 2025-04-05 1 site Stand-alone
    Other conditions: Physical Performance, Cognitive Performance
    View official trial listing →
  • Completed NCT NCT07604519

    Multi-Ingredient Supplementation in Professional Football Players

    Not yet reported Vizja University in Warsaw 97 participants Est. completion 2026-06-30 5 sites Stand-alone
    Other conditions: Sports Performance, Cognitive Performance During Physical Activity, Fatigue, Recovery, Football Players
    View official trial listing →
  • Not yet recruiting NCT NCT07656051

    Taurine and Nitrate Supplementation on Thermoregulatory in T2DM

    Not yet reported University of Portsmouth 18 participants Est. completion 2028-04-01
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07682402

    Taurine Supplementation in Adolescents With Post-COVID Condition

    Not yet reported, Not yet reported University of Alberta 30 participants Est. completion 2028-12-31 Stand-alone
    Other conditions: Long COVID, Post COVID-19 Condition, PASC Post Acute Sequelae of COVID 19
    View official trial listing →
  • Completed NCT NCT07696052

    Phosphatidylserine, Taurine, and Caffeine for Cognitive Fatigue in Professional Football Players

    Not yet reported Vizja University in Warsaw 65 participants Est. completion 2026-09-08 2 sites Stand-alone
    Other conditions: Mental Fatigue, Cognitive Performance, Athletic Performance, Soccer Performance, Decision Making
    View official trial listing →
  • Not yet recruiting NCT NCT07711899

    Plasma Taurine in Older Women With Obesity: Impact of Metabolic Phenotype and Combined Exercise

    Not yet reported University of Sao Paulo 36 participants Est. completion 2030-03-01
    Other conditions: Obesity (BMI>30), Metabolically Healthy Obesity, Metabolically Unhealty Obese
    View official trial listing →
  • Active, not recruiting NCT NCT07730255

    Exercise and Taurine Supplementation on Intramuscular Fat in Older Women With Obesity

    Not yet reported University of Sao Paulo 44 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Obesity (BMI>30)
    View official trial listing →
  • Not yet recruiting NCT NCT07771166

    Effects of N-Acyl Taurines on Incretin Levels in Healthy Subjects

    Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2028-12 Stand-alone
    Other conditions: Cardiometabolic Conditions
    View official trial listing →
  • Completed NCT NCT07771309

    Study of Metabolic Absorption Rates of DHA-Taurine as a Source of Omega-3 Fatty Acids

    Not yet reported University of Copenhagen 6 participants Est. completion 2025-10-29 1 site Stand-alone
    Other conditions: Omega-3 Fatty Acids, Absorption of Omega-3, Pharmacokinetics
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Active comparator Taurine, Taurine

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.